ViroMed Medical AG

medical devices

About

Viromed is revolutionizing medical technology with cold atmospheric plasma (CAP) for applications in wound healing, intensive care medicine and room air sterilization. As a pioneer in cold plasma technology, Viromed has been conducting basic research on viruses and bacteria since 2004, and now covers the entire value chain from research and development, production and logistics to the marketing and distribution of its innovative PulmoPlas® and ViroCAP® devices. The company has an extensive distribution network, reaching over 1,100 hospitals, 2,000 retirement homes, 7,000 pharmacies, and 12,000 medical practices in Germany, as well as established distribution partners for international sales. Viromed Medical AG (VMED; ISIN: DE000A3MQR65) is listed on the Frankfurt Stock Exchange.

Technologies

Outlook WordPress.org Mobile Friendly Apache

Keywords

medical equipment manufacturing medical research and development european healthcare market healthcare services market expansion medical device logistics wound healing medical solutions healthcare logistics pulmoplas medical device manufacturing logistics respiratory treatment medical research healthtech animal medical solutions government medical device commercialization virocap medical device sales strategic partnerships plasma care products medical product distribution hospital supplies exclusively medical plasma devices medical device distribution medical innovation product development respiratory therapy devices b2b

Location

105 Hauptstrasse, Rellingen, Schleswig-Holstein, Germany, 25462

Related Companies

Companies in the same industry